Verve Therapeutics, Inc.

Industry

  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Technologies
      • Genomics-Proteomics
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
See more in Biomedtracker

Latest on Verve Therapeutics, Inc.

Scrip

Verve Moves Toward Lilly Opt-In For PCSK9 Program With Phase Ib Results

 
• By Alaric DeArment

Verve Therapeutics is looking to submit its opt-in package to partner Eli Lilly after the announcement of positive data from the Phase Ib study of VERVE-102 in heterozygous familial hypercholesterolem

Scrip

Lilly Licenses Sangamo’s Capsid Technology For CNS Gene Therapy

 
• By Alaric DeArment

Who: Sangamo Therapeutics/Eli Lilly What: Lilly signed a deal with Sangamo to license the gene therapy company’s STAC-BBB adeno-associated viral vector capsid for up to five potential neurological

Scrip

Peter Marks’ Departure From FDA Rattles Biopharma Industry

 
• By Mandy Jackson

News that US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) director Peter Marks submitted his resignation, effective 5 April, late in the day on 28 March shook the b

Scrip

Beam Gets Important Proof Of Concept For AATD Therapy

 
• By Alaric DeArment

Beam Therapeutics sees BEAM-302 as having potential for eventual accelerated approval from the US Food and Drug Administration in alpha-1 antitrypsin deficiency (AATD) after announcing positive early